2012China Medical HeraldRequires access

Analysis on the effect of Irbesartan in inflammatory factors of patients with hypertension

Xiaoping Guo

Open publisher page 0 citations

Abstract

Objective To investigate of Irbesartan in inflammatory factors of patients with hypertension.Methods 293 patients with hypertension were divided into experiment group(193 cases) and control group(100 cases),who were randomly selected in our hospital.Control group received conventional antihypertensive treatment,patients in the experiment group were given Irbesartan on the basis of the control group.Results After treatment,the diastolic blood pressure and pulse pressure of two groups were significantly differences(P 0.05),but systolic blood pressure had no significant difference(P 0.05);inflammation factor of patients in the experiment group were lower than before treatment and that of control group(P 0.05).Conclusion Irbesartan not only reduce blood pressure in patients with essential hypertension but also reduce the levels of inflammatory factors in serum,thereby reducing the risk of adverse events in patients.

About this research paper

What this paper is about

Objective To investigate of Irbesartan in inflammatory factors of patients with hypertension.Methods 293 patients with hypertension were divided into experiment group(193 cases) and control group(100 cases),who were randomly selected in our hospital.Control group received conventional antihypertensive treatment,patients in the experiment group were given Irbesartan on the basis of the control group.Results After treatment,the diastolic blood pressure and pulse pressure of two groups were significantly differences(P 0.05),but systolic blood pressure had no significant difference(P 0.05);inflammation factor of patients in the experiment group were lower than before treatment and that of control group(P 0.05).Conclusion Irbesartan not only reduce blood pressure in patients with essential hypertension but also reduce the levels of inflammatory factors in serum,thereby reducing the risk of adverse events in patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate of Irbesartan in inflammatory factors of patients with hypertension.Methods 293 patients with hypertension were divided into experiment group(193 cases) and control group(100 cases),who were randomly selected in our hospital.Control group received conventional antihypertensive treatment,patients in the experiment group were given Irbesartan on the basis of the control group.Results After treatment,the diastolic blood pressure and pulse pressure of two groups were significantly differences(P 0.05),but systolic blood pressure had no significant difference(P 0.05);inflammation factor of patients in the experiment group were lower than before treatment and that of control group(P 0.05).Conclusion Irbesartan not only reduce blood pressure in patients with essential hypertension but also reduce the levels of inflammatory factors in serum,thereby reducing the risk of adverse events in patients.

Key concepts: Irbesartan, Medicine, Blood pressure, Internal medicine, Inflammation, Essential hypertension, Adverse effect, Cardiology

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis on the effect of Irbesartan in inflammatory factors of patients with hypertension — Research Paper | ScholarLens